Jump to content Jump to main menu Jump to sub menu


Whether you need full comprehensive safety support or simply ad hoc safety reporting, QED’s highly experienced Pharmacovigilance group can cost effectively cover the entire range of clinical trial safety tasks and responsibilities.

QED’s Pharmacovigilance department routinely undertake all contracted activities required for the management of safety information from clinical trials and have a proven track record across multiple therapeutic areas and phases (I-IV).

We appreciate the critical importance of ensuring that an effective pharmacovigilance system is in place for all clinical studies. Our expertise guarantees that serious adverse event information and all other safety information is collected and reported to the appropriate individuals and organisations within the required timelines on all studies we work on.

The flexibility of QED’s Pharmacovigilance offering means that we can tailor our solutions to our individual client’s needs across the entire pharmacovigilance process: